Designation: Regional President—Middle East, Türkiye, and Levant
Global headquarters: U.S.
Mokhtar assumed his current role in 2020. The company generated $3.1 billion in revenues from emerging markets in 2021. In 2022, the company signed an MoU with the U.A.E. to decrease mortality from noncommunicable diseases. Mokhtar was previously regional strategy lead for the Middle East and Africa at Pfizer and general manager for the GCC countries for Upjohn, a division of Pfizer. Mokhtar is also co-chair of the healthcare committee AmCham Abu Dhabi and a board member of the U.S.- U.A.E. Business Council.